Skip to Main Content

Paper Details

Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Clin Infect Dis
26
2023
CCP, COVID-19, SARS, SARS-CoV, SARS-CoV-2, convalescent plasma, participants, person
Author NameAffiliation
Shmuel ShohamThe Johns Hopkins University School of Medicine
Evan M BlochThe Johns Hopkins University School of Medicine
Arturo CasadevallThe Johns Hopkins Bloomberg School of Public Health
Arturo CasadevallThe Johns Hopkins Bloomberg School of Public Health
Bryan LauThe Johns Hopkins Bloomberg School of Public Health
Kelly A GeboThe Johns Hopkins University School of Medicine
Arash NaeimUniversity of California los angeles
Judith S CurrierUniversity of California los angeles
Judith S CurrierUniversity of California los angeles
Douglas A JabsThe Johns Hopkins University School of Medicine
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Andrew PekoszThe Johns Hopkins Bloomberg School of Public Health
Martin S ZandUniversity of Rochester
Aaron A R TobianThe Johns Hopkins University School of Medicine
  • 1 - 14

Datasets

Release 1.2